Stefan Pierrou

1.9k total citations
24 papers, 1.4k citations indexed

About

Stefan Pierrou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Stefan Pierrou has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Stefan Pierrou's work include Diabetes Treatment and Management (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Receptor Mechanisms and Signaling (3 papers). Stefan Pierrou is often cited by papers focused on Diabetes Treatment and Management (7 papers), Neuroendocrine Tumor Research Advances (3 papers) and Receptor Mechanisms and Signaling (3 papers). Stefan Pierrou collaborates with scholars based in Sweden, Germany and United States. Stefan Pierrou's co-authors include Sven Enerbäck, Peter Carlsson, Lena Samuelsson, Peter J.P. Croucher, Werner Koch, Thomas Lengauer, Georg H. Waetzig, Philip Rosenstiel, Stefan Schreiber and Monika Stoll and has published in prestigious journals such as Journal of Biological Chemistry, Nature Genetics and The EMBO Journal.

In The Last Decade

Stefan Pierrou

23 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Pierrou Sweden 14 800 381 206 201 166 24 1.4k
Claude Besmond France 26 952 1.2× 286 0.8× 242 1.2× 143 0.7× 304 1.8× 72 1.9k
Jiehong Pan United States 16 639 0.8× 288 0.8× 212 1.0× 283 1.4× 285 1.7× 29 1.6k
Lorita Dudus United States 16 1.3k 1.6× 705 1.9× 379 1.8× 250 1.2× 234 1.4× 19 2.0k
Byron Baron Malta 18 752 0.9× 230 0.6× 106 0.5× 194 1.0× 136 0.8× 72 1.5k
Stefan Ries Germany 23 801 1.0× 269 0.7× 94 0.5× 158 0.8× 170 1.0× 36 1.5k
Maya R. Vilà Spain 19 911 1.1× 167 0.4× 153 0.7× 117 0.6× 107 0.6× 31 1.3k
Christopher B. Jackson Finland 23 1.3k 1.6× 131 0.3× 151 0.7× 180 0.9× 87 0.5× 53 1.9k
G Grimber France 24 1.2k 1.4× 312 0.8× 168 0.8× 233 1.2× 73 0.4× 48 2.1k
Massimo P. Crippa Italy 23 1.1k 1.4× 170 0.4× 97 0.5× 264 1.3× 149 0.9× 51 1.8k

Countries citing papers authored by Stefan Pierrou

Since Specialization
Citations

This map shows the geographic impact of Stefan Pierrou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Pierrou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Pierrou more than expected).

Fields of papers citing papers by Stefan Pierrou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Pierrou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Pierrou. The network helps show where Stefan Pierrou may publish in the future.

Co-authorship network of co-authors of Stefan Pierrou

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Pierrou. A scholar is included among the top collaborators of Stefan Pierrou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Pierrou. Stefan Pierrou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zetterberg, Henrik, et al.. (2024). Phase 1b trial on the safety, tolerability and immunogenicity of anti‐amyloid vaccine ALZ‐101 in subjects with MCI or mild AD. Alzheimer s & Dementia. 20(S8). 2 indexed citations
3.
Pronk, Amanda C. M., Trea C.M. Streefland, Reshma A. Lalai, et al.. (2024). Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE*3-Leiden.CETP mice. Cardiovascular Research. 120(17). 2179–2190. 5 indexed citations
4.
5.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2021). Glucagon Like Peptide-1 receptor imaging in individuals with Type 2 Diabetes. Journal of Nuclear Medicine. 63(5). jnumed.121.262506–jnumed.121.262506. 6 indexed citations
6.
Eriksson, Olof, Torsten Haack, Youssef Hijazi, et al.. (2020). Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes. Scientific Reports. 10(1). 16758–16758. 34 indexed citations
7.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2020). Imaging of the Glucagon Receptor in Subjects with Type 2 Diabetes. Journal of Nuclear Medicine. 62(6). 833–838. 8 indexed citations
8.
Eriksson, Olof, Irina Velikyan, Torsten Haack, et al.. (2019). Assessment of glucagon receptor occupancy by Positron Emission Tomography in non-human primates. Scientific Reports. 9(1). 14960–14960. 7 indexed citations
9.
Velikyan, Irina, Torsten Haack, Martin Bossart, et al.. (2019). First-in-class positron emission tomography tracer for the glucagon receptor. EJNMMI Research. 9(1). 17–17. 18 indexed citations
10.
Wang, Xin, Magdalena Mazurkiewicz, Ellin‐Kristina Hillert, et al.. (2016). The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. Scientific Reports. 6(1). 26979–26979. 133 indexed citations
11.
Martin, Kenneth, Arun Kumar, Stefan Pierrou, et al.. (2015). A novel CX3CR1 antagonist eluting stent reduces stenosis by targeting inflammation. Biomaterials. 69. 22–29. 20 indexed citations
12.
Lind, Ulrika, et al.. (2009). Down regulation of TRPC1 by shRNA reduces mechanosensitivity in mouse dorsal root ganglion neurons in vitro. Neuroscience Letters. 457(1). 3–7. 25 indexed citations
13.
Beaumont, Hanneke, Ann‐Cathrine Jönsson‐Rylander, Stefan Pierrou, et al.. (2008). The role of GABAAreceptors in the control of transient lower oesophageal sphincter relaxations in the dog. British Journal of Pharmacology. 153(6). 1195–1202. 10 indexed citations
14.
Pierrou, Stefan, Per Broberg, Rory O’Donnell, et al.. (2006). Expression of Genes Involved in Oxidative Stress Responses in Airway Epithelial Cells of Smokers with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(6). 577–586. 169 indexed citations
15.
Stoll, Monika, Brit Corneliussen, Christine Costello, et al.. (2004). Genetic variation in DLG5 is associated with inflammatory bowel disease. Nature Genetics. 36(5). 476–480. 336 indexed citations
16.
Särnstrand, Bengt, et al.. (1999). N, N′-Diacetyl-l-cystine—the Disulfide Dimer of N-acetylcysteine—Is a Potent Modulator of Contact Sensitivity/Delayed Type Hypersensitivity Reactions in Rodents. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1174–1184. 33 indexed citations
17.
Pierrou, Stefan, et al.. (1996). Characterization of the Human Forkhead Gene FREAC-4. Journal of Biological Chemistry. 271(35). 21094–21099. 25 indexed citations
18.
Pierrou, Stefan, Sven Enerbäck, & Peter Carlsson. (1995). Selection of High-Affinity Binding Sites for Sequence-Specific, DNA Binding Proteins from Random Sequence Oligonucleotides. Analytical Biochemistry. 229(1). 99–105. 23 indexed citations
19.
20.
Pierrou, Stefan, et al.. (1992). Ionic Strength Dependence of the Binding of Methylene Blue to Chromatin and Calf Thymus DNA. Journal of Biomolecular Structure and Dynamics. 9(4). 667–679. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claude Besmond Breakdown of academic impact, for papers by Jiehong Pan Breakdown of academic impact, for papers by Lorita Dudus Breakdown of academic impact, for papers by Byron Baron Breakdown of academic impact, for papers by Stefan Ries Breakdown of academic impact, for papers by Maya R. Vilà Breakdown of academic impact, for papers by Christopher B. Jackson Breakdown of academic impact, for papers by G Grimber Breakdown of academic impact, for papers by Massimo P. Crippa
Rankless by CCL
2026